IP Library Granted Patent US 8,014,862
Granted Patent B2
US 8,014,862 · App. 12/945,853 · Granted Sep 6, 2011

Anterior active housing subcutaneous positioning methods

Assignee: Cameron Health, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,014,862
App. No.
12/945,853
Granted
Sep 6, 2011
Kind
B2
Abstract

A subcutaneous cardiac device includes a subcutaneous electrode and a housing coupled to the subcutaneous electrode by a lead with a lead wire. The subcutaneous electrode is adapted to be implanted in a frontal region of the patient so as to overlap a portion of the patient's heart.

Claims (24)

1. A method of treating a patient using an implantable defibrillator, the method comprising:

implanting an implantable defibrillator canister having a generally square shape with rounded corners in the patient at a position on the left side of the ribcage under the arm, the implantable defibrillator canister having a footprint in the range of 30-50 square centimeters and a depth in the range of about 1.2 cm;

implanting a first implantable defibrillator lead having at least a first lead electrode and coupled to the implantable defibrillator canister in the patient such that the first lead electrode is disposed along the sternum, the first lead electrode having a length of about 2-10 centimeters and a diameter of about 1-5 millimeters; and

delivering defibrillation therapy between the canister electrode and the lead electrode.

2. The method of claim 1 wherein the housing is made of titanium.

3. The method of claim 1 wherein the implantable defibrillator canister and first implantable defibrillator lead are disposed in the frontal region of the patient such that each can be implanted using anatomical landmarks without requiring fluoroscopy.

4. The method of claim 1 wherein the implantable defibrillator consists of the implantable defibrillator canister and the first implantable defibrillator lead, such that the method does not include any further implanting steps.

5. The method of claim 1 wherein the implantable defibrillator includes a second implantable defibrillator lead having at least a second lead electrode, and the method includes:

implanting the second implantable defibrillator lead in the patient such that the second lead electrode is also disposed along the sternum;

wherein the first lead electrode is disposed on the right side of the sternum, and the second lead electrode is disposed along the left side of the sternum.

6. The method of claim 5 wherein the second lead electrode has a length of about 2-10 centimeters and a diameter of about 1-5 millimeters.

7. The method of claim 5 wherein the second implantable defibrillator lead also includes a third electrode disposed near the second electrode with a gap therebetween, wherein the second and third electrodes plus the gap have a total length of about 2-10 centimeters, with the third electrode disposed at a tip of the second implantable defibrillator lead.

8. A method of treating a patient using an implantable defibrillator, the method comprising:

implanting an implantable defibrillator canister having a generally oval shape in the patient at a position on the left side of the ribcage under the arm, the implantable defibrillator canister having a footprint in the range of 30-50 square centimeters and a depth in the range of about 1.2 cm;

implanting a first implantable defibrillator lead having at least a first lead electrode and coupled to the implantable defibrillator canister in the patient such that the first lead electrode is disposed along the sternum, the first lead electrode having a length of about 2-10 centimeters and a diameter of about 1-5 millimeters; and

delivering defibrillation therapy between the canister electrode and the lead electrode.

9. The method of claim 8 wherein the housing is made of titanium.

10. The method of claim 8 wherein the implantable defibrillator canister and first implantable defibrillator lead are disposed in the frontal region of the patient such that each can be implanted using anatomical landmarks without requiring fluoroscopy.

11. The method of claim 8 wherein the implantable defibrillator consists of the implantable defibrillator canister and the first implantable defibrillator lead, such that the method does not include any further implanting steps.

12. The method of claim 8 wherein the implantable defibrillator includes a second implantable defibrillator lead having at least a second lead electrode, and the method includes:

implanting the second implantable defibrillator lead in the patient such that the second lead electrode is also disposed along the sternum;

wherein the first lead electrode is disposed on the right side of the sternum, and the second lead electrode is disposed along the left side of the sternum.

13. The method of claim 12 wherein the second lead electrode has a length of about 2-10 centimeters and a diameter of about 1-5 millimeters.

14. The method of claim 12 wherein the second implantable defibrillator lead also includes a third electrode disposed near the second electrode with a gap therebetween, wherein the second and third electrodes plus the gap have a total length of about 2-10 centimeters, with the third electrode disposed at a tip of the second implantable defibrillator lead.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2012
From: OSTROFF, ALAN H.
To: CAMERON HEALTH, INC.
Reel/Frame 029542/0569 →
AFFIRMATION OF ASSIGNMENT OF PAUL ERLINGER FOR US 7,149,575 AND RELATED CASES Recorded Dec 28, 2012
From: ERLINGER, PAUL
To: CAMERON HEALTH, INC.
Reel/Frame 029549/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2011
From: OSTROFF, ALAN H.; ERLINGER, PAUL; BARDY, GUST H.
To: CAMERON HEALTH, INC.
Reel/Frame 026675/0757 →
Continuity (7)
Continuation 11555424 · Nov 1, 2006
Continuation 10150434 · May 17, 2002
Continuation In Part 10011956 · Nov 5, 2001
Continuation In Part 09940599 · Aug 27, 2001
Continuation In Part 09663607 · Sep 18, 2000
Continuation In Part 09663606 · Sep 18, 2000
Related Publication 20110060379A1 · Mar 10, 2011